ImmuCell Corporation (ICCC) scores 75 out of 100 on boothcheck's 11-model valuation framework. Verdict: Good The estimated fair value is 11.03, representing a 52% margin of safety. Quantitative score: 70/100. Qualitative score: 90/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.